The American Board of Pathology has certified Dr. Meghan Driscoll in neuropathology.
Dr. Driscoll offers a diverse range of diagnostic services, including surgical, autopsy and ocular pathology consultations. She is trained in frozen sections, and histochemistry and immunohistochemistry for lesions of the brain, spinal cord, pituitary, meninges, as well as muscle biopsy and peripheral nerve evaluations. Additionally, Dr. Driscoll is experienced with molecular analysis of brain tumors, including MGMT promoter methylation, FISH (1p/19q, EGFR), and the significance of other tumor-specific mutations for their diagnostic and prognostic value. Through these studies, gliomas can be further characterized to allow prediction of a prognosis and chemosensitivity. Dr. Driscoll works closely with neurosurgeons, oncologists and molecular pathologists to provide state of the art evaluation of these tumors.
Dr. Driscoll is also board certified in anatomic and clinical pathology and earned her medical degree from the University of Washington in Seattle. She completed her residency in anatomic and clinical pathology, as well as a fellowship in neuropathology from the University of Utah in Salt Lake City, where she also served as Chief Resident from 2015 to 2016.